These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD. Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104 [Abstract] [Full Text] [Related]
4. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension? Wu RA, Kailasam MT, Cervenka JH, Parmer RJ, Kennedy BP, Ziegler MG, O'Connor DT. J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871 [Abstract] [Full Text] [Related]
5. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients. Pasini AF, Garbin U, Nava MC, Stranieri C, Pellegrini M, Boccioletti V, Luchetta ML, Fabrizzi P, Lo Cascio V, Cominacini L. Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354 [Abstract] [Full Text] [Related]
6. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE? Rayner B. Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845 [Abstract] [Full Text] [Related]
7. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients? Ruzicka M, Coletta E, Leenen FH. Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368 [Abstract] [Full Text] [Related]
8. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension. Chang PC, Kriek E, van Brummelen P. J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470 [Abstract] [Full Text] [Related]
9. Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients. Armentano RL, Graf S, Ramírez AJ, Espinosa JD, Brandani L, Baglivo H, Sánchez R. Medicina (B Aires); 2001 Feb; 61(5 Pt 1):535-40. PubMed ID: 11721319 [Abstract] [Full Text] [Related]
10. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina). Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, Crepaldi G. Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047 [Abstract] [Full Text] [Related]
11. The sympathetic nervous system and ischaemic heart disease. Remme WJ. Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738 [Abstract] [Full Text] [Related]
12. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension. Lafleche A, Gautier S, Topouchian J, Wilmet CS, Girerd X, Safar ME, Benetos A. Clin Pharmacol Ther; 1998 Jul; 64(1):96-105. PubMed ID: 9695724 [Abstract] [Full Text] [Related]
13. Human in vivo study of the renin-angiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk. Usinger L, Ibsen H, Linneberg A, Azizi M, Flambard B, Jensen LT. Clin Physiol Funct Imaging; 2010 Mar; 30(2):162-8. PubMed ID: 20113315 [Abstract] [Full Text] [Related]
14. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial. Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS. Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099 [Abstract] [Full Text] [Related]
15. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers. Spinar J, Vítovec J, Soucek M, Dusek L, Pavlík T, CORD Invesigators. Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614 [Abstract] [Full Text] [Related]
16. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR. Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [Abstract] [Full Text] [Related]
17. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects. Lang CC, Stein CM, He HB, Wood AJ. Clin Pharmacol Ther; 1996 Jun; 59(6):668-74. PubMed ID: 8681492 [Abstract] [Full Text] [Related]
18. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. Ambühl PM, Tissot AC, Fulurija A, Maurer P, Nussberger J, Sabat R, Nief V, Schellekens C, Sladko K, Roubicek K, Pfister T, Rettenbacher M, Volk HD, Wagner F, Müller P, Jennings GT, Bachmann MF. J Hypertens; 2007 Jan; 25(1):63-72. PubMed ID: 17143175 [Abstract] [Full Text] [Related]
19. Sympathetic nervous system activity and alpha-adrenergic responsiveness in older hypertensive humans. Supiano MA, Hogikyan RV, Sidani MA, Galecki AT, Krueger JL. Am J Physiol; 1999 Mar; 276(3):E519-28. PubMed ID: 10070019 [Abstract] [Full Text] [Related]
20. Effects of ramipril on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young normotensive subjects with successfully repaired coarctation of aorta: a randomized cross-over study. Brili S, Tousoulis D, Antoniades C, Vasiliadou C, Karali M, Papageorgiou N, Ioakeimidis N, Marinou K, Stefanadi E, Stefanadis C. J Am Coll Cardiol; 2008 Feb 19; 51(7):742-9. PubMed ID: 18279739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]